Results 121 to 130 of about 1,423 (197)

Tumefactive Demyelination

open access: yes, 2017
Sean Dodson   +2 more
openaire   +2 more sources

Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease [PDF]

open access: yes, 2023
De Vere-Tyndall, Anthony   +7 more
core   +1 more source

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination. [PDF]

open access: yesJ Neurol Sci
Guido FS   +13 more
europepmc   +1 more source

VEXAS syndrome-associated tumefactive demyelination. [PDF]

open access: yesJ Neurol
Eatz T   +4 more
europepmc   +1 more source

The detection of serum anti-brain antibodies in a cohort of patients with tumefactive demyelinating lesions of the CNS. [PDF]

open access: yes
Background: A tumefactive demyelinating lesion (TDL) is defined as being at least 2cm in diameter, whilst conventional multiple sclerosis (CMS) lesions usually have a diameter less than 9 mm.
Boyle, Marie Therese
core  

Tumefactive Demyelination: A Clinico-Radiological Dilemma

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2021
Swati, Kumar   +4 more
openaire   +2 more sources

Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination. [PDF]

open access: yesMult Scler
Zhao-Fleming HH   +10 more
europepmc   +1 more source

Tumefactive demyelination versus tumor; A diagnostic dilemma: Role of electron microscopy

open access: yesIndian Journal of Pathology and Microbiology, 2018
Paresh Doshi   +3 more
doaj   +1 more source

Deep Learning MRI Models for the Differential Diagnosis of Tumefactive Demyelination versus <i>IDH</i> Wild-Type Glioblastoma. [PDF]

open access: yesAJNR Am J Neuroradiol
Conte GM   +16 more
europepmc   +1 more source

Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange [PDF]

open access: yes, 2013
Feliu-Rey, Eloisa   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy